Personal information

No personal information available

Activities

Collapse all

Works (5)

LncRNA EILA promotes CDK4/6 inhibitor resistance in breast cancer by stabilizing cyclin E1 protein.

Science advances
2023-10-06 | Journal article
DOI: 10.1126/sciadv.adi3821
PMID: 37801505
PMC: PMC10558131
Contributors: cai zijie; Qianfeng Shi; Yudong Li; Jin L; Li S; Lok Lam Wong; Wang J; Jiang X; Zhu M; Lin J et al.
Source: Self-asserted source
Shunying Li

LncRNA DILA1 inhibits Cyclin D1 degradation and contributes to tamoxifen resistance in breast cancer.

Nature communications
2020-11-02 | Journal article
DOI: 10.1038/s41467-020-19349-w
PMID: 33139730
PMC: PMC7608661
Contributors: Shi Q; Li Y; Li S; Liang Jin; Lai H; Wu Y; Cai Z; Zhu M; Li Q; Li Y et al.
Source: Self-asserted source
Shunying Li

Circulating Tumor DNA Predicts the Response and Prognosis in Patients With Early Breast Cancer Receiving Neoadjuvant Chemotherapy.

JCO precision oncology
2020-03-27 | Journal article
DOI: 10.1200/po.19.00292
PMID: 32923909
PMC: PMC7450928
Contributors: Li S; Lai H; Liu J; Liu Y; Jin L; Li Y; Liu F; Gong Y; Guan Y; Yi X et al.
Source: Self-asserted source
Shunying Li

Gasdermin E suppresses tumour growth by activating anti-tumour immunity.

Nature
2020-03-11 | Journal article
DOI: 10.1038/s41586-020-2071-9
PMID: 32188940
PMC: PMC7123794
Contributors: Zhang Z; Zhang Y; Shiyu Xia; Qing Kong; Li S; Liu X; Caroline Junqueira; Karla F Meza-Sosa; 0000-0003-4898-2114; Ansara J et al.
Source: Self-asserted source
Shunying Li

LIN9 confers paclitaxel resistance in triple negative breast cancer cells by upregulating CCSAP.

Science China. Life sciences
2019-08-14 | Journal article
DOI: 10.1007/s11427-019-9581-8
PMID: 31420851
Contributors: Lai H; Wang R; Li S; Shi Q; Cai Z; Li Y; Liu Y
Source: Self-asserted source
Shunying Li
How many people are using ORCID?